Article
Human cytomegalovirus seropositivity is associated with decreased survival in glioblastoma patients.
Neuro-oncology Advances
(2019)
Disciplines
Publication Date
May 1, 2019
DOI
10.1093/NOAJNL/VDZ020
Citation Information
Haidn Foster, Keenan Piper, Lisa DePledge, Hsin-Fang Li, et al.. "Human cytomegalovirus seropositivity is associated with decreased survival in glioblastoma patients." Neuro-oncology Advances Vol. 1 Iss. 1 (2019) Available at: http://works.bepress.com/hsin-fang-li/28/